UCSF Psoriasis Center
Welcome,         Profile    Billing    Logout  
 4 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Liao, Wilson
NCT03293030: Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis

Completed
4
18
US
Dupilumab, Dupixent
University of California, San Francisco, Regeneron Pharmaceuticals, Sanofi
Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema, Atopic Dermatitis and Related Conditions
02/23
02/23
TIG, NCT04645355: Guselkumab Immunogenetics

Recruiting
4
25
US
Guselkumab
University of California, San Francisco, Janssen Biotech, Inc.
Psoriasis Guttate, Plaque Psoriasis
01/25
01/25
NCT04404075: Skin Tracker: A Mobile Health App to Monitor Skin Disease Activity and Treatment Use

Completed
N/A
11
US
SkinTracker Mobile App
University of California, San Francisco
Atopic Dermatitis, Eczema
05/23
05/23
Thibodeaux, Quinn
NCT03662685: Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris

Active, not recruiting
4
15
US
Goeckerman Therapy, Combination Treatment with Phototherapy and Crude Coal Tar, Goeckerman Regimen, Crude Coal Tar Only, Coal tar, Phototherapy Only, Ultraviolet B, Narrowband ultraviolet B, NB-UVB, UVB phototherapy, Phototherapy, Light treatment
University of California, San Francisco, National Psoriasis Foundation
Psoriasis Vulgaris, Psoriasis
05/24
05/24
NCT03293030: Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis

Completed
4
18
US
Dupilumab, Dupixent
University of California, San Francisco, Regeneron Pharmaceuticals, Sanofi
Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema, Atopic Dermatitis and Related Conditions
02/23
02/23

Download Options